CAR-T in relapsed refractory high-grade glioma and glioblastoma - who, what, when and how?
{{output}}
Recurrent high-grade gliomas have a dismal prognosis. This review article aimed to explore and help answer the questions about which group of patients would benefit from chimeric antigen receptor therapy (CAR-T) cell therapy in this setting, the timing of inte... ...